G Marri

892 total citations · 1 hit paper
10 papers, 671 citations indexed

About

G Marri is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pharmacology. According to data from OpenAlex, G Marri has authored 10 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Molecular Biology and 1 paper in Pharmacology. Recurrent topics in G Marri's work include Diabetes Management and Research (4 papers), Diabetes Treatment and Management (3 papers) and Metabolism, Diabetes, and Cancer (2 papers). G Marri is often cited by papers focused on Diabetes Management and Research (4 papers), Diabetes Treatment and Management (3 papers) and Metabolism, Diabetes, and Cancer (2 papers). G Marri collaborates with scholars based in United Kingdom and Italy. G Marri's co-authors include Ellis Samols, V. Marks, Renato Palumbo, Маркс, J. P. P. Tyler, Paolo Brunetti and Fausto Santeusanio and has published in prestigious journals such as The Lancet, Diabetes and Acta Diabetologica.

In The Last Decade

G Marri

8 papers receiving 559 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PROMOTION OF INSULIN SECRETION BY GLUCAGON

1965 402 citations Ellis Samols, G Marri et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G Marri United Kingdom	5	392	388	179	150	82	10	671
H. Ketterer United States	9	347 0.9×	403 1.0×	162 0.9×	100 0.7×	73 0.9×	14	716
D. S. Turner United Kingdom	10	762 1.9×	537 1.4×	253 1.4×	138 0.9×	170 2.1×	13	1.1k
C. Verdonk United States	11	299 0.8×	183 0.5×	150 0.8×	68 0.5×	153 1.9×	13	529
M. G. Cartechini Italy	12	703 1.8×	397 1.0×	133 0.7×	291 1.9×	124 1.5×	16	858
R R Revers United States	12	316 0.8×	226 0.6×	203 1.1×	128 0.9×	139 1.7×	15	559
D. Chisholm Australia	11	222 0.6×	130 0.3×	161 0.9×	74 0.5×	141 1.7×	15	437
M Fullerton Australia	12	410 1.0×	233 0.6×	230 1.3×	40 0.3×	55 0.7×	18	768
I. Gottesman Canada	11	302 0.8×	128 0.3×	147 0.8×	91 0.6×	150 1.8×	18	504
James Salter Canada	11	213 0.5×	161 0.4×	102 0.6×	28 0.2×	156 1.9×	26	423
R F James United Kingdom	10	193 0.5×	238 0.6×	96 0.5×	88 0.6×	23 0.3×	14	354

Countries citing papers authored by G Marri

Since Specialization

Citations

This map shows the geographic impact of G Marri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Marri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Marri more than expected).

Fields of papers citing papers by G Marri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Marri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Marri. The network helps show where G Marri may publish in the future.

Co-authorship network of co-authors of G Marri

This figure shows the co-authorship network connecting the top 25 collaborators of G Marri. A scholar is included among the top collaborators of G Marri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Marri. G Marri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Brunetti, Paolo, et al.. (1969). Propriet� insulino-stimolanti della glibenclamide (HB 419) in soggetti normali. Studi comparativi con la tolbutamide. Acta Diabetologica. 6(1). 283–298. 2 indexed citations

2.

Brunetti, Paolo & G Marri. (1968). I fattori intestinali della secrezione insulinica con particolare riguardo al ruolo del glucagone. Acta Diabetologica. 5(4). 513–531.

3.

Marri, G, et al.. (1968). GLUCAGON IN SULPHONYLUREA HYPOGLYCEMIA ?. The Lancet. 291(7537). 303–304. 10 indexed citations

4.

Marri, G, et al.. (1966). [Stimulation of insulin secretion in humans by means of prolonged infusion of glucagon].. PubMed. 42(20). 1422–6. 1 indexed citations

5.

Samols, Ellis, G Marri, & V. Marks. (1966). Interrelationship of Glucagon, Insulin and Glucose: The Insulinogenic Effect of Glucagon. Diabetes. 15(12). 855–866. 146 indexed citations

6.

Marri, G, J. P. P. Tyler, Маркс, & Ellis Samols. (1966). [Stimulation of insulin secretion in man by means of glucagon].. PubMed. 57(65). 2733–7. 4 indexed citations

7.

Samols, Ellis, G Marri, & V. Marks. (1965). PROMOTION OF INSULIN SECRETION BY GLUCAGON. The Lancet. 286(7409). 415–416. 402 indexed citations breakdown →

8.

Samols, Ellis, et al.. (1965). STIMULATION OF GLUCAGON SECRETION BY ORAL GLUCOSE. The Lancet. 286(7425). 1257–1259. 103 indexed citations

9.

Marri, G, et al.. (1963). [On the therapy of various forms of liver insufficiency by "essential" phospholipids].. PubMed. 17. 28–30. 1 indexed citations

10.

Marri, G, et al.. (1961). [The recent introduction in therapy of a new antitussive drug: oxolamine].. PubMed. 52. 3758–60. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact